AN
Alto Neuroscience, Inc.
SEC filingPharmaceuticals · Mountain View, CA
Amount raised$50Msold at filing
Total offering$50M
Investors in the raise7count reported to the SEC
FiledOct 27, 2025first sale Oct 21, 2025
Form D does not name the investors. If a news report names them, they appear here.
Named in the filing
Adam SavitzExecutive Officer
Amit EtkinExecutive Officer, Director
Nicholas C. SmithExecutive Officer
Gwill C. YorkDirector
Husseini Nixon ManjiDirector
Christopher Nixon CoxDirector
Raymond Nixon SanchezDirector
Andrew Nixon DreyfusDirector
Michael HanleyExecutive Officer
Executive officers, directors and promoters as listed on the Form D.